STORM in the News

Biotech and Money Executive & Expert Insights: STORM Therapeutics leads the way in RNA epigenetics

Biotech and Money Editor, Louise Fordham talks to CEO Keith Blundy about the latest developments at STORM Therapeutics and its plans for the year ahead

Biotech and Money article

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2023 Dates To be Confirmed